Lexeo Therapeutics Aktie
WKN DE: A3EXD2 / ISIN: US52886X1072
24.03.2025 18:11:15
|
Lexeo Therapeutics Stock Jumps 23% Despite Widened Q4 Net Loss
(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) is trading at $3.39, up 23.25 percent or $0.68 during Monday's trading, despite reporting a widened net loss of $25.9 million for the fourth quarter compared to $14.2 million in the prior period.
The stock opened at $2.99 and has traded between $2.99 and $3.98 so far, compared to a previous close of $2.71 on the Nasdaq. Trading volume is 4.16 million shares, significantly above the average of 342,756. The stock's 52-week range is $2.32 to $19.50.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lexeo Therapeutics Inc Regsitered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Lexeo Therapeutics Inc Regsitered Shsmehr Analysen
Aktien in diesem Artikel
Lexeo Therapeutics Inc Regsitered Shs | 2,83 | 7,60% |
|